Cannabis: The Good, the Bad, and the Ugly

Submitted by lisebram on

ADAA Webinar Presented by Martin Paulus, PhD, Scientific Council Chair

The use of cannabis in the U.S. has undergone a dramatic change over the past two decades.  Starting with the campaign to legalize the use of cannabis in the 90s, use, attitudes and risk perception have changed in both adolescent and adult population.  In this presentation, four recent research publications will be reviewed that highlight a more cautious approach towards cannabis.

Rajendra Morey, MD, MS

Submitted by lisebram on
Author Photo
Rajendra Morey, MD, MS

Rajendra Morey is an expert in PTSD neuroimaging research, traumatic brain injury research and heads the ENIGMA Psychiatry Genomics Consortium for PTSD. 

Thomas Adams, PhD

Submitted by lisebram on
Author Photo

Tom Adams has an established track record with research in anxiety disorders, PTSD and OCD. Having trained at Yale University before moving to University of Kentucky, he has a K23 looking at effect of transcranial direct current stimulation (tDCS) on fear extinction learning with neuroimaging correlates. 

Shawn Jones, PhD, MHS

Submitted by lisebram on
Author Photo
Dr. Shawn Jones

Dr. Shawn Jones is an Assistant Professor in the Counseling Program in the Psychology Department at Virginia Commonwealth University. He received his doctorate in Clinical Psychology with an emphasis on Children and Families from the University of North Carolina at Chapel Hill and was a Child Clinical Psychology Predoctoral intern at UCLA. Dr.

Polycarpe Bagereka

Submitted by lisebram on
Author Photo
Polycarpe Bagereka

Polycarpe Bagereka is an undergraduate Chemistry major at Carleton College and a summer research intern at the National Institutes of Health (NIH). Polycarpe has a broad research background ranging from wet-lab immunotherapy applications to clinical research in both solid tumors and hematologic malignancies. He has assisted on pioneering projects such as identifying a biomarker for quiescent AML progenitor cells with implications for future targeted chemotherapies. Polycarpe currently interns at Dr.

Raffael Kalisch, PhD

Submitted by lisebram on
Author Photo
Raffael Kalisch, PhD

Raffael Kalisch, PhD is trying to unravel the mechanisms underlying resilience to the detrimental effects of adversity on mental health. He does this in small-sample laboratory studies of stress and emotion regulation mechanisms, often involving neuroimaging, as well as in large-sample longitudinal cohort studies in which stressor exposure, mental health, and resilience factors are monitored repeatedly and at high sampling frequency, such as to identify processes of adaptation that allow stressor-exposed individuals to stay mentally healthy.

Raquel Gur, MD, PhD

Submitted by lisebram on

Dr. Gur is Professor of Psychiatry Neurology and Radiology at the University of Pennsylvania Perelman School of Medicine where she directs the Neuropsychiatry Section and the Schizophrenia Research Center and is Vice Chair of Research Development in the Department of Psychiatry. Her combined training in Psychology, Neurology and Psychiatry has provided the tools to pursue an academic career working with basic and clinical neuroscientists to advance the understanding of schizophrenia.

Doron Gothelf, MD

Submitted by lisebram on

Prof. Gothelf is adult, child and adolescent psychiatrist. He completed a postdoctoral research fellowship at the Neuroscience Center, Stanford University and is a full professor of psychiatry at Sackler Faculty of Medicine, Tel Aviv University. Since 2010, Prof. Gothelf has served as director of the Division at Sheba Medical Center. Prof.